Primary Site >> Colorectal Cancer

Gene >> NDRG4

  • 2009
  • 2010
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
PMID: 19535783
 Ref: Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.
PMID: 20068171
 Ref: The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia.
PMID: 22019796
Ref: Quantification of methylated markers with a multiplex methylation-specific technology.
PMID: 22194633
 Ref: Stool DNA testing for the detection of colorectal neoplasia in patients with inflammatory bowel disease.
PMID: 23347191
Ref: Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
PMID: 23639600
 Ref: FOXE1 and SYNE1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia.
PMID: 24280874
Ref: Detection of colorectal serrated polyps by stool DNA testing: comparison with fecal immunochemical testing for occult blood (FIT).
PMID: 24465639
Ref: Multitarget stool DNA testing for colorectal-cancer screening.
PMID: 24645800
Ref: Stool methylated DNA markers decrease following colorectal cancer resection--implications for surveillance.
PMID: 24993691
Ref: DNA methylation analysis of SFRP2, GATA4/5, NDRG4 and VIM for the detection of colorectal cancer in fecal DNA.
PMID: 25202404
 Ref: Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood.
PMID: 25538088
Ref: Quantitative detection of methylated NDRG4 gene as a candidate biomarker for diagnosis of colorectal cancer.
PMID: 25663916
Ref: NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients.
PMID: 25749388
Ref: Stool DNA methylation assays in colorectal cancer screening.
PMID: 26401070
Ref: [Fecal Biomarker for Colorectal Cancer Diagnosis].
PMID: 26524859
 Ref: NDRG4 stratifies the prognostic value of body mass index in colorectal cancer.
PMID: 26515606
Ref: Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.
PMID: 26922358
Ref: Field Cancerization in Sporadic Colon Cancer.
PMID: 27114416
Ref: DNA methylation based biomarkers in colorectal cancer: A systematic review.
PMID: 27385266
 Ref: Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.
PMID: 28044229
Ref: NDRG4, an early detection marker for colorectal cancer, is specifically expressed in enteric neurons.
PMID: 28524415
Ref: DNA methylation of CMTM3, SSTR2, and MDFI genes in colorectal cancer.
PMID: 28782576
Ref: Is methylation analysis of SFRP2, TFPI2, NDRG4, and BMP3 promoters suitable for colorectal cancer screening in the Korean population?
PMID: 29142517
Ref: Identification and validation of colorectal neoplasia-specific methylation biomarkers based on CTCF-binding sites.
PMID: 29371978
 Ref: Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
PMID: 29313389
Ref: Analysis of DNA Methylation at Specific Loci in Stool Samples Detects Colorectal Cancer and High-grade Dysplasia in Patients with Inflammatory Bowel Disease.
PMID: 29775793
Ref: The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
PMID: 30024936
Ref: A combined literature and in silico analysis enlightens the role of the NDRG family in the gut.
PMID: 30033230
Ref: Facile profiling of molecular heterogeneity by microfluidic digital melt.
PMID: 30263958